Literature DB >> 20079807

Signalling pathways in vasculogenic mimicry.

Yvette W J Paulis1, Patricia M M B Soetekouw, Henk M W Verheul, Vivianne C G Tjan-Heijnen, Arjan W Griffioen.   

Abstract

Solid tumour growth is dependent on the development of an adequate blood supply. For years, sprouting angiogenesis has been considered an exclusive mechanism of tumour vascularization. However, over the last years, several other mechanisms have been identified, including vessel-co-option, intussusception, recruitment of endothelial precursor cells (EPCs) and even mechanisms that do not involve endothelial cells, a process called vasculogenic mimicry (VM). The latter describes a mechanism by which highly aggressive tumour cells can form vessel-like structures themselves, by virtue of their high plasticity. VM has been observed in several tumour types and its occurrence is strongly associated with a poor prognosis. This review will focus on signalling molecules and cascades involved in VM. In addition, we will discuss the presence of VM in relation to ongoing cancer research. Finally, we describe the clinical significance of VM regarding anti-angiogenesis treatment modalities. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079807     DOI: 10.1016/j.bbcan.2010.01.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  75 in total

1.  [Biejiajian Pills inhibits hepatoma carcinoma cell vasculogenic mimicry by suppressing RhoA/ROCK signaling pathway].

Authors:  Haiyan An; Junhao Lin; Haitao Sun; Lili Xu; Jiaqi Su; Chunyu He; Jiamin Zeng; Peixiang Liang; Songqi He
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications.

Authors:  Dawn A Kirschmann; Elisabeth A Seftor; Katharine M Hardy; Richard E B Seftor; Mary J C Hendrix
Journal:  Clin Cancer Res       Date:  2012-04-02       Impact factor: 12.531

3.  The involvement of Notch signaling in melanoma vasculogenic mimicry.

Authors:  Amalia Vartanian; Galina Gatsina; Irina Grigorieva; Elico Solomko; Vladislav Dombrovsky; Anatoly Baryshnikov; Eugenia Stepanova
Journal:  Clin Exp Med       Date:  2012-05-25       Impact factor: 3.984

4.  Inhibition of TGF-β signaling, vasculogenic mimicry and proinflammatory gene expression by isoxanthohumol.

Authors:  Annegret Serwe; Kristina Rudolph; Timm Anke; Gerhard Erkel
Journal:  Invest New Drugs       Date:  2011-02-22       Impact factor: 3.850

5.  Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG.

Authors:  Gengqiang Ling; Shiyong Wang; Zhenhua Song; Xinlin Sun; Yijing Liu; Xiaodan Jiang; Yingqian Cai; Mouxuan Du; Yiquan Ke
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

Review 6.  CD133-targeted niche-dependent therapy in cancer: a multipronged approach.

Authors:  Anthony B Mak; Caroline Schnegg; Chiou-Yan Lai; Subrata Ghosh; Moon Hee Yang; Jason Moffat; Mei-Yu Hsu
Journal:  Am J Pathol       Date:  2014-02-28       Impact factor: 4.307

Review 7.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

8.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

9.  Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.

Authors:  Francesca Spinella; Valentina Caprara; Valeriana Di Castro; Laura Rosanò; Roberta Cianfrocca; Pier Giorgio Natali; Anna Bagnato
Journal:  J Mol Med (Berl)       Date:  2012-09-11       Impact factor: 4.599

10.  Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasion.

Authors:  Meng Tong; Byungdo B Han; Andrew S Holpuch; Ping Pei; Lingli He; Susan R Mallery
Journal:  Exp Cell Res       Date:  2013-01-29       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.